Sumitomo Chemical Company Limited;Sumitomo Dainippon Pharma Co., Ltd.
发明人:
申请号：
EP14843405.3
公开号：
EP3045448A4
申请日:
2014.09.12
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention provides a compound represented by the following formula (I) or its pharmaceutically acceptable salt: [wherein, R 1 represents optionally substituted C 1-4 alkyl, n shows integer of 1 to 4, R 2 represents optionally substituted C 1-4 alkyl or hydrogen atom, R 3 represents optionally substituted C 1-4 alkyl, R 4a , R 4b , R 4c , and R 4d , similarly or differently, represent optionally substituted C 6-14 aryl, optionally substituted C 1-4 alkyl, or hydrogen atom and the like, A represents optionally substituted C 6-14 aryl or optionally substituted 5 to 11 membered heteroaryl].
